Skip to main navigation Skip to search Skip to main content

Paraneoplastische syndromen

Translated title of the contribution: Paraneoplastic syndromes: the importance of early recognition and treatment
  • Emma J. van Dijk
  • , Lieneke F.M. Ariens
  • , Rutger Heinen
  • , Britt B.M. Suelmann

Research output: Contribution to journal › Review article › peer-review

Abstract

Paraneoplastic syndromes are complexes of symptoms that can arise as a result of an immune response to an underlying malignancy. Various types of paraneoplastic syndromes exist: endocrine, metabolic, dermatological, rheumatological, hematological, and neurological. These syndromes occur more frequently than we might think, but their incidence varies greatly depending on the syndrome and the type of cancer. They can be difficult to recognize due to the wide variety of symptom complexes, and are frequently the first manifestation of a malignancy. Paraneoplastic syndromes can arise from humoral factors or autoimmunity, with immune-mediated paraneoplastic syndromes often not responding adequately to treatment of the underlying malignancy. Early recognition of a paraneoplastic syndrome is crucial both for diagnosing a malignancy at an earlier stage and for preserving the patient's quality of life.

Translated title of the contributionParaneoplastic syndromes: the importance of early recognition and treatment
Original languageDutch
JournalNederlands Tijdschrift voor Geneeskunde
Volume170
Publication statusPublished - 19 May 2026

Fingerprint

Dive into the research topics of 'Paraneoplastic syndromes: the importance of early recognition and treatment'. Together they form a unique fingerprint.

Cite this